Sort
15,842 grants matching “pancreatic cancer”
Live-cell Activity Architecture in Cancer
$900,601Jin Zhang · University Of California, San Diego · R35 · FY2024 · CA
CCR, LGI, Flow Cytometry Core Facility
$900,397Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Role of Neurotrophins in the Development of the Mammalian Nervous System
$900,224Lino Tessarollo · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
SPORE in Pancreatic Cancer
$900,000University Of Texas Md Anderson Can Ctr · P20 · FY2004 · CA
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2004 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2001 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2005 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2003 · DK
MOLECULAR PATHOGENESIS OF DIGESTIVE DISEASES
$900,000Stanford University · P30 · FY2002 · DK
SPORE in Pancreatic Cancer
$900,000University Of Texas Md Anderson Can Ctr · P20 · FY2003 · CA
SPORE in Pancreatic Cancer
$900,000University Of Alabama At Birmingham · P20 · FY2003 · CA
The MYC Transcription Factor Network and the Path to Cancer
$899,999Robert Neil Eisenman · Fred Hutchinson Cancer Center · R35 · FY2024 · CA
Targeting undruggable RAS for cancer treatment
$899,999Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2022 · CA
Biomarker Validation in Pancreatic Cystic Neoplasms
$898,256Diane M Simeone · New York University School Of Medicine · U01 · FY2023 · CA
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$898,049Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2017 · CA
Cancer Gene Discovery to Identify Targetable Targets
$896,280Carlo M Croce · Ohio State University · R35 · FY2019 · CA
DNA Topoisomerases as nuclear and mitochondrial targets of Anticancer Drugs
$895,684Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$895,633Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2021 · CA
Frameshift peptide vaccine for the prevention Lynch syndrome-associated gastrointestinal cancer HHSN2612015000391 TORFP: 2018-E12 POP: 9/17/2018 to 3/16/2021
$894,832Steven Monroe Lipkin · Weill Medical Coll Of Cornell Univ · N01 · FY2018 · CA
Targeting undruggable RAS for cancer treatment
$894,826Channing J Der · Univ Of North Carolina Chapel Hill · R35 · FY2019 · CA
Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer
$894,497Gloria M. Petersen · Mayo Clinic Rochester · U01 · FY2020 · CA
Biomarkers and mechanisms in cancer associated thrombosis
$893,486Jeffrey Zwicker · Beth Israel Deaconess Medical Center · U01 · FY2018 · HL
Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis
$892,860Matthew J. Flick · Univ Of North Carolina Chapel Hill · U01 · FY2019 · HL
Molecular signatures for liver cancer diagnosis and treatment stratification
$891,493Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
BASE TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND ENDPOINT BIOMARKERS; TASK ORDER TITLE: EFGR AND KRAS VACCINE
$890,873Chinthalapally V. Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2020 · CA